Christine Nash

Christine Nash

Directeur/Membre du Conseil chez RALLYBIO CORPORATION

Fortune : - $ au 31/08/2026

53 ans
Health Technology
Commercial Services
Consumer Services

Profil

Ms. Christine A. Nash is an Independent Director at Rallybio Corp.
She is on the Board of Directors at Rallybio Corp.
Ms. Nash was previously employed as a Principal by Chatiemac Consulting LLC, a Chief Commercial Officer & Senior Vice President by Hyperion Therapeutics, Inc., a Marketing Director by CoTherix, Inc., a Principal by Eli Lilly & Co., a Product Manager by Genesoft Pharmaceuticals, Inc., a Principal by Imana, Inc., and a Principal by Oncology Therapeutics Network Corp.
She also served on the board at CM Group LLC.
She received her undergraduate degree from Stanford University and an MBA from Stanford University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
19/12/2025 0 ( -.--% ) - $ 31/08/2026

Postes actifs de Christine Nash

SociétésPosteDébut
RALLYBIO CORPORATION Directeur/Membre du Conseil 04/04/2022

Anciens postes connus de Christine Nash

SociétésPosteFin
Directeur/Membre du Conseil 01/09/2022
HYPERION THERAPEUTICS INC Corporate Officer/Principal 01/05/2015
Sales & Marketing 01/02/2007
Chatiemac Consulting LLC
Corporate Officer/Principal -
Imana, Inc.
Corporate Officer/Principal -
Voir l'expérience en détail de Christine Nash

Formation de Christine Nash

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

62

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées10

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Distribution Services

Technology Services

Imana, Inc.

Health Technology

Chatiemac Consulting LLC

  1. Bourse
  2. Insiders
  3. Christine Nash
🔇